AKT1 and breast cancer: Previous studies established that dieckol, a major component, inhibits the proliferation and invasion of MCF-7 breast cancer cells by suppressing MMP9 expression through the inhibition of PI3K/Akt, Wnt/β-catenin, and NF-κB signaling [8].